🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalSouth Korea Ozempic availability — Samsung Medical Center experience Page 4

South Korea Ozempic availability — Samsung Medical Center experience

hyun_seoul Tue, Jun 2, 2026 at 11:28 PM 25 replies 525 viewsPage 4 of 5
sarah_TO
Member
278
1,234
Sep 2024
Toronto, CA
Jun 4, 2026 at 4:31 AM#16

From the other side of the consultation, briefly. There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

36 11andrew_nyc, Dr.EndoEP, GraceAZ_72 and 33 others
Reply Quote Save Share Report
james_edin
Member
289
1,234
Sep 2024
Edinburgh, UK
Jun 4, 2026 at 9:10 AM#17

Clinical perspective, offered as context rather than as advice. Order of operations matters more than any single choice here: establish a baseline, change one thing, wait long enough for it to express itself, then measure again under the same conditions.

Last edited: Jun 4, 2026 at 11:10 AM
35 10Dr.PathRoch, mona_PHX, andrew_nyc and 32 others
Reply Quote Save Share Report
mel_PDX
Member
189
890
Dec 2024
Portland, OR
Jun 4, 2026 at 1:50 PM#18
james_edin said:
Order of operations matters more than any single choice here: establish a baseline, change one thing, wait long enough for it to express itself, then…

Can confirm the pattern james_edin describes. The dose-response is real but shallow at the top. Across STEP 1 and STEP 4 the gap between 1.7mg and 2.4mg is a couple of percentage points of body weight on average, and the average is carrying a wide spread — plenty of people at 1.7mg sit above the 2.4mg mean. If a dose is working and tolerable, "working" is the relevant variable, not "maximal".

If somebody has the primary source to hand I would rather cite it than paraphrase it.

Last edited: Jun 4, 2026 at 7:50 PM
34 9PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 31 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.PainCLE
Senior Member
1,234
6,234
Mar 2024
Cleveland, OH
Jun 4, 2026 at 6:29 PM#19
james_edin said:
Order of operations matters more than any single choice here: establish a baseline, change one thing, wait long enough for it to express itself, then…

Adding the part of the answer the thread has not reached. If two explanations both fit, the useful question is which one predicts something the other does not. That is answerable; arguing about which sounds more plausible is not.

Last edited: Jun 4, 2026 at 9:29 PM
33 8bbq_ray_KC, oliver_london, tane_welly and 30 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Jun 4, 2026 at 11:08 PM#20

Moderator note: two posts asking for a source have been merged into one. Please search the thread before asking again. Tagging this one for the weekly digest.

Last edited: Jun 5, 2026 at 1:08 AM
11 11PurityPaulOR, MaxMetOK, MounjBrad and 8 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register